Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.

about

Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.

Item

http://www.wikidata.org/entity/Q40563598

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunoglobulin heavy light cha ...... serum free light chain ratio.

@en

type

Item

label

Immunoglobulin heavy light cha ...... serum free light chain ratio.

@en

prefLabel

Immunoglobulin heavy light cha ...... serum free light chain ratio.

@en

P1476

Immunoglobulin heavy light cha ...... serum free light chain ratio.

@en

P2093

Brian Spencer

http://www.w3.org/2001/XMLSchema#string

David C Seldin

http://www.w3.org/2001/XMLSchema#string

Fangui Sun

http://www.w3.org/2001/XMLSchema#string

Richard M O'Hara

http://www.w3.org/2001/XMLSchema#string

Tatiana Prokaeva

http://www.w3.org/2001/XMLSchema#string

Vaishali Sanchorawala

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

Update on treatment of light chain amyloidosis

Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis.

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features.

Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.

P304

214-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13506129.2016.1219715

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lawreen H Connors

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27677679

http://www.w3.org/2001/XMLSchema#string